Icu Medical [ICUI] vs Avantor [AVTR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Icu Medical wins in 10 metrics, Avantor wins in 9 metrics, with 0 ties. Icu Medical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricIcu MedicalAvantorBetter
P/E Ratio (TTM)-25.2714.15Icu Medical
Price-to-Book Ratio1.421.55Icu Medical
Debt-to-Equity Ratio66.4067.49Icu Medical
PEG Ratio0.10-0.40Avantor
EV/EBITDA12.4312.70Icu Medical
Profit Margin (TTM)-1.56%10.31%Avantor
Operating Margin (TTM)4.88%7.63%Avantor
EBITDA Margin (TTM)4.88%7.63%Avantor
Return on Equity-1.78%11.73%Avantor
Return on Assets (TTM)1.84%3.24%Avantor
Free Cash Flow (TTM)$113.83M$692.00MAvantor
1-Year Return-31.88%-43.54%Icu Medical
Price-to-Sales Ratio (TTM)1.271.46Icu Medical
Enterprise Value$4.12B$13.54BAvantor
EV/Revenue Ratio1.742.03Icu Medical
Gross Profit Margin (TTM)37.91%32.92%Icu Medical
Revenue per Share (TTM)$97$10Icu Medical
Earnings per Share (Diluted)$-1.52$1.01Avantor
Beta (Stock Volatility)0.830.98Icu Medical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Icu Medical vs Avantor Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Icu Medical-0.57%2.74%-1.64%-9.87%-13.77%-22.73%
Avantor-1.40%20.69%11.47%2.95%-8.81%-32.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Icu Medical-31.88%-18.61%-36.37%17.79%227.00%333.80%
Avantor-43.54%-28.98%-41.63%-1.45%-1.45%-1.45%

News Based Sentiment: Icu Medical vs Avantor

Icu Medical

News based Sentiment: MIXED

ICU Medical is presenting a mixed investment story this month. While analysts suggest significant undervaluation and insider buying indicates confidence, the company is grappling with declining sales, high debt, and a recent FDA warning. These conflicting signals create a complex picture for investors.

View Icu Medical News Sentiment Analysis

Avantor

News based Sentiment: MIXED

October was a dynamic month for Avantor, with a surge in stock price due to activist investor activity balanced by mixed analyst ratings and a cautious adjustment of price targets. The upcoming earnings release on October 29th will be crucial in determining the company's trajectory.

View Avantor News Sentiment Analysis

Performance & Financial Health Analysis: Icu Medical vs Avantor

MetricICUIAVTR
Market Information
Market Cap i$3.06B$9.74B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i259,01010,132,900
90 Day Avg. Volume i280,25011,070,000
Last Close$121.38$14.09
52 Week Range$107.00 - $196.26$10.82 - $26.14
% from 52W High-38.15%-46.10%
All-Time High$321.70 (Aug 06, 2018)$44.37 (Sep 20, 2021)
% from All-Time High-62.27%-68.24%
Growth Metrics
Quarterly Revenue Growth-0.08%-0.01%
Quarterly Earnings Growth-0.08%-0.30%
Financial Health
Profit Margin (TTM) i-0.02%0.10%
Operating Margin (TTM) i0.05%0.08%
Return on Equity (TTM) i-0.02%0.12%
Debt to Equity (MRQ) i66.4067.49
Cash & Liquidity
Book Value per Share (MRQ)$85.71$9.22
Cash per Share (MRQ)$12.15$0.66
Operating Cash Flow (TTM) i$138.83M$681.80M
Levered Free Cash Flow (TTM) i$247.93M$688.84M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Icu Medical vs Avantor

MetricICUIAVTR
Price Ratios
P/E Ratio (TTM) i-25.2714.15
Forward P/E i17.8712.65
PEG Ratio i0.10-0.40
Price to Sales (TTM) i1.271.46
Price to Book (MRQ) i1.421.55
Market Capitalization
Market Capitalization i$3.06B$9.74B
Enterprise Value i$4.12B$13.54B
Enterprise Value Metrics
Enterprise to Revenue i1.742.03
Enterprise to EBITDA i12.4312.70
Risk & Other Metrics
Beta i0.830.98
Book Value per Share (MRQ) i$85.71$9.22

Financial Statements Comparison: Icu Medical vs Avantor

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ICUIAVTR
Revenue/Sales i$604.70M$1.58B
Cost of Goods Sold i$394.59M$1.05B
Gross Profit i$210.11M$534.90M
Research & Development i$23.29MN/A
Operating Income (EBIT) i$29.59M$147.40M
EBITDA i$82.47M$230.80M
Pre-Tax Income i$-10.91M$85.70M
Income Tax i$4.57M$21.20M
Net Income (Profit) i$-15.48M$64.50M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ICUIAVTR
Cash & Equivalents i$289.70M$315.70M
Total Current Assets i$1.42B$2.28B
Total Current Liabilities i$549.02M$2.03B
Long-Term Debt i$1.54B$3.28B
Total Shareholders Equity i$1.99B$6.10B
Retained Earnings i$674.68M$2.27B
Property, Plant & Equipment i$466.20MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ICUIAVTR
Operating Cash Flow i$90.80M$86.60M
Capital Expenditures i$-14.62MN/A
Free Cash Flow i$34.47M$81.30M
Debt Repayment i$-48.08M$-31.30M
Common Stock Repurchase iN/A$-4.90M

Short Interest & Institutional Ownership Analysis

MetricICUIAVTR
Shares Short i1.45M25.06M
Short Ratio i4.642.26
Short % of Float i0.07%0.05%
Average Daily Volume (10 Day) i259,01010,132,900
Average Daily Volume (90 Day) i280,25011,070,000
Shares Outstanding i24.52M680.80M
Float Shares i23.90M663.95M
% Held by Insiders i0.03%0.01%
% Held by Institutions i1.13%1.06%

Dividend Analysis & Yield Comparison: Icu Medical vs Avantor

MetricICUIAVTR
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A